SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-036902
Filing Date
2020-08-05
Accepted
2020-08-05 17:01:01
Documents
55
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q arna-10q_20200630.htm   iXBRL 10-Q 2010803
2 EX-10.1 arna-ex101_148.htm EX-10.1 31766
3 EX-10.2 arna-ex102_395.htm EX-10.2 146679
4 EX-10.3 arna-ex103_394.htm EX-10.3 140771
5 EX-10.8 arna-ex108_393.htm EX-10.8 53905
6 EX-31.1 arna-ex311_8.htm EX-31.1 15027
7 EX-31.2 arna-ex312_6.htm EX-31.2 15417
8 EX-32.1 arna-ex321_15.htm EX-32.1 8830
  Complete submission text file 0001564590-20-036902.txt   6095683

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA arna-20200630.xsd EX-101.SCH 29636
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arna-20200630_cal.xml EX-101.CAL 39099
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arna-20200630_def.xml EX-101.DEF 83087
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20200630_lab.xml EX-101.LAB 243335
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20200630_pre.xml EX-101.PRE 174685
14 EXTRACTED XBRL INSTANCE DOCUMENT arna-10q_20200630_htm.xml XML 1009101
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 201078409
SIC: 2834 Pharmaceutical Preparations